Pharmacokinetics of high-dose weekly ambisome (liposomal amphotericin B) antifungal prophylaxis in pediatric bone marrow transplantation (BMT) patients

被引：3
|
作者：
Mehta, PA [1 ]
Vinks, AA [1 ]
Filipovich, AH [1 ]
Vaughn, GA [1 ]
Fearing, DN [1 ]
Sper, C [1 ]
Davies, SM [1 ]
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2005年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2004.12.263
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
263
引用
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [41] Safety, Tolerability, and Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Pediatric Patients
    Seibel, Nita L.
    Shad, Aziza T.
    Bekersky, Ihor
    Groll, Andreas H.
    Gonzalez, Corina
    Wood, Lauren V.
    Jarosinski, Paul
    Buell, Donald
    Hope, William W.
    Walsh, Thomas J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (02)
  • [42] DISPOSITION OF HIGH-DOSE BUSULFAN IN PEDIATRIC-PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION
    REGAZZI, MB
    LOCATELLI, F
    BUGGIA, I
    BONETTI, F
    ZECCA, M
    PREGNOLATO, M
    QUAGLINI, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (01) : 45 - 52
  • [43] High-Dose Liposomal Amphotericin B in the Therapy of Systemic Candidiasis in Neonates
    A. Juster-Reicher
    O. Flidel-Rimon
    M. Amitay
    S. Even-Tov
    E. Shinwell
    E. Leibovitz
    European Journal of Clinical Microbiology and Infectious Diseases , 2003, 22 : 603 - 607
  • [44] High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates
    Juster-Reicher, A
    Flidel-Rimon, O
    Amitay, M
    Even-Tov, S
    Shinwell, E
    Leibovitz, E
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (10) : 603 - 607
  • [45] PHARMACOKINETICS OF FLUDARABINE IN PAEDIATRIC PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION(BMT)
    Misra, Ruchira
    Nath, Christa
    Shaw, Peter J.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 839 - 839
  • [46] Cost-benefit assessment of antifungal prophylaxis with liposomal amphotericin B in neutropenic patients
    Penack, Olaf
    Reinhold, Thomas
    Thiel, Eckhard
    Blau, Igor Wolfgang
    ONKOLOGIE, 2007, 30 (12): : 621 - 626
  • [47] Pediatric invasive mucormycosis cured with high dose liposomal amphotericin B
    Erbey, Fatih
    Kocabas, Emine
    Bayram, Ibrahim
    Soyupak, Sureyya
    Gumurdulu, Derya
    Tanyeli, Atila
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2012, 60 (04): : 375 - 379
  • [48] PHARMACOKINETICS OF HIGH-DOSE THIOTEPA IN CHILDREN UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    KLETZEL, M
    KEARNS, GL
    WELLS, TG
    THOMPSON, HC
    BONE MARROW TRANSPLANTATION, 1992, 10 (02) : 171 - 175
  • [49] ENCEPHALOPATHY WITH PARKINSONIAN FEATURES (PF) IN CHILDREN FOLLOWING BONE-MARROW TRANSPLANTATIONS (BMT) TREATED WITH HIGH-DOSE AMPHOTERICIN-B (HDAB)
    MOTT, SH
    PACKER, RJ
    VEZINA, LG
    DINNDORF, PA
    QUINONES, RR
    NEUROLOGY, 1993, 43 (04) : A206 - A206
  • [50] COSTS OF ANTIFUNGAL PROPHYLAXIS AFTER BONE-MARROW TRANSPLANTATION - A MODEL COMPARING ORAL FLUCONAZOLE, LIPOSOMAL AMPHOTERICIN AND ORAL POLYENES AS PROPHYLAXIS AGAINST OROPHARYNGEAL INFECTIONS
    STEWART, A
    POWLES, R
    HEWETSON, M
    ANTRUM, J
    RICHARDSON, C
    MEHTA, J
    PHARMACOECONOMICS, 1995, 8 (04) : 350 - 361
12345